Press release
Inotropic Agents Market Size, Industry Analysis And Forecast, Report 2024 To 2033
Inotropic Agents Market
According to The Business Research Company's, The inotropic agents market size has grown rapidly in recent years. It will grow from $2.32 billion in 2023 to $2.59 billion in 2024 at a compound annual growth rate (CAGR) of 11.2%. The growth in the historic period can be attributed to education and awareness initiatives, expansion of cardiac treatment options, development of safer agents, improved patient outcomes, regulatory approvals.
The inotropic agents market size is expected to see rapid growth in the next few years. It will grow to $4.01 billion in 2028 at a compound annual growth rate (CAGR) of 11.6%. The growth in the forecast period can be attributed to growing cardiovascular disease burden, advancements in drug delivery systems, personalized medicine approach, increasing research funding, demand for combination therapies. Major trends in the forecast period include patient education and awareness, targeting cardiomyopathies, focus on heart failure management, combination therapies, improved safety profiles.
Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/inotropic-agents-global-market-report
Market Drivers and Trends:
The surge in the prevalence of cardiovascular diseases is driving the inotropic agent market. Cardiovascular diseases (CVDs) refer to diseases of the vascular system and heart functioning. Inotropic agents are used in the treatment of cardiovascular diseases to improve the contractility and function of the heart, tackle cardiac shock, and slow the heart rate as they help the heart contract more powerfully, thereby increasing blood flow. So this helps boost the inotropic agent market. For instance, in October 2022, according to the reports shared by the Centers for Disease Control and Prevention, a US-based government agency, heart diseases were the leading cause of death in the US. About 697,000 people died from heart disease in 2020, which was roughly 1 in every 5 deaths. About 20.1 million adults were suffering from coronary artery disease. Each year, about 805,000 people in the US suffer from a heart attack. Furthermore, in August 2022, according to the American College of Cardiology, a US-based nonprofit medical association, the risk of stroke was expected to increase by 33.8 percent to 15 million from 2025 to 2060. Therefore, the surge in the prevalence of cardiovascular diseases is propelling the inotropic agent market forward.
Drug approval is a key trend gaining popularity in the inotropic agents market. Major companies in the market are developing innovative new products and drugs to sustain their position in the market. For instance, in April 2022, Bristol-Myers Squibb., a US-based pharmaceutical developer and manufacturer, received regulatory approval for Camzyos™ (mavacamten) from the U.S. Food and Drug Administration (FDA), a US-based national public health agency and regulator. It is used in the treatment of class II-III obstructive hypertrophic cardiomyopathy (HCM) to improve functional capacity and symptoms. This medication works by inhibiting the excessive contraction of the heart muscle. It is a selective inhibitor of cardiac myosin, a protein involved in muscle contraction. It is typically prescribed to individuals who have symptomatic obstructive HCM and have not adequately responded to other treatment options, such as beta-blockers or calcium channel blockers.
Key Benefits for Stakeholders:
• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=10711&type=smp
Major Key Players of the Market:
Pfizer Inc., GSK plc, Novartis AG, Mylan N.V., Boehringer Ingelheim International GmbH, AstraZeneca plc, Johnson & Johnson, Bayer AG, Merck & Co. Inc., Bristol-Myers Squibb Company, Cipla Ltd., Eli Lilly And Company, Sanofi S.A., Baxter International Inc., Hikma Pharmaceuticals plc, Sun Pharmaceuticals Industries Ltd., Cadila Pharmaceuticals Ltd., AbbVie Inc., Allergan plc, Amgen Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Fresenius Kabi AG, Genentech Inc., GlaxoSmithKline plc, Intas Pharmaceuticals Ltd., Lupin Limited, Regeneron Pharmaceuticals Inc., Roche Holding AG, BioNTech SE
Inotropic Agents Market 2024 Key Insights:
• The inotropic agents market size will grow to $4.01 billion in 2028 at a compound annual growth rate (CAGR) of 11.6%.
• Surging Cardiovascular Diseases Propel Growth In The Inotropic Agent Market
• Bristol-Myers Squibb's Mavacamten Receives Fda Approval, Setting A Trend In The Inotropic Agents Market
• North America was the largest region in the inotropic agents market in 2023
We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/Customise?id=10711&type=smp
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Inotropic Agents Market Size, Industry Analysis And Forecast, Report 2024 To 2033 here
News-ID: 3755485 • Views: …
More Releases from The Business Research Company
n-Butanol Market to Grow at 5% CAGR, Reaching $4.52 Billion by 2029
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
n-Butanol Market Outlook: How is the Market Expected to Grow by 2025?
The market size for n-butanol has been experiencing a consistent growth in the past few years. The market is projected to expand from $3.55 billion in 2024 to $3.72 billion in 2025, demonstrating a Compound Annual Growth Rate…
Acrylic Powder Coating Market is Anticipated to Expand upto $1.98 Billion in 202 …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What Is the Forecasted Market Growth Rate of the Acrylic Powder Coating Industry?
The market for acrylic powder coating has seen sustained growth over the past few years. Expectations are for it to expand from a value of $1.53 billion in 2024 to $1.6 billion in 2025, reflecting a 4.5% compound…
L-lactide Industry Expected to Reach $2.64 Billion by 2029 at 12.7% CAGR
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
L-lactide Market Value Projection: How Much Will the Market Size by 2025?
The market size for l-lactide has experienced quick expansion in the past few years. The value is projected to increase from $1.45 billion in 2024 to $1.63 billion in 2025, representing a compound annual growth rate (CAGR) of 12.6%.…
Graphene Market is Anticipated to Expand upto $3.41 Billion in 2029
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What Is the Forecasted Market Growth Rate of the Graphene Industry?
In the latest years, the size of the graphene market has seen a substantial expansion. It is projected that it will rise from $1.32 billion in 2024 to $1.6 billion in 2025, with a compound annual growth rate (CAGR) of…
More Releases for Inotropic
Surging Cardiovascular Diseases Propel Growth In The Inotropic Agent Market: Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Inotropic Agents Market Through 2025?
The market size for inotropic agents has expanded significantly in the previous years. The market is expected to increase from $2.56 billion in 2024 to $2.84 billion in 2025, indicating a compound annual growth rate (CAGR) of…
Inotropic Agent Market Key Players, Share and Forecast Outlook
On May 13 , 2025, Exactitude Consultancy., Ltd. released a research report titled "Inotropic Agent Market". This report covers the global Inotropic Agent market sales, sales volume, price, market share, ranking of major companies, etc., and provides a detailed analysis by region, country, product type, and application. It also forecasts the market size of automotive kick sensors based on market patterns from 2020 to 2034 and future market trends. Along…
Inotropic Agent Market Key Players, Share and Forecast Outlook
On May 12 , 2025, Exactitude Consultancy., Ltd. released a research report titled "Inotropic Agent Market". This report covers the global Inotropic Agent market sales, sales volume, price, market share, ranking of major companies, etc., and provides a detailed analysis by region, country, product type, and application. It also forecasts the market size of automotive kick sensors based on market patterns from 2020 to 2034 and future market trends. Along…
Surging Cardiovascular Diseases Propel Growth In The Inotropic Agent Market Driv …
What market dynamics are playing a key role in accelerating the growth of the inotropic agents market?
The increase in occurrences of cardiovascular diseases is fueling the growth of the inotropic agent market. Cardiovascular diseases, which pertain to disorders of the heart and vascular system, are often treated with inotropic agents. These substances enhance the heart's contractility, help manage cardiac shock, and slow down the heart rate by assisting the heart…
Inotropic Agents Market: Exploring Size, Growth Rate, Drivers, and Trends
Expanding Scope and Implications of Inotropic Agents in Cardiac Health
What Is The Projected Market Size Of The Global Inotropic Agents Market And Its Growth Rate?
The inotropic agents market has seen a significant growth, driven by the medical advancements and the rising awareness of cardiac health.
• Market size in 2024: $2.56 billion
• Market size in 2025: $2.84 billion (11.1% CAGR)
• Expected Market size in 2029: $4.52 billion (12.3% CAGR)
The key factors…
Insights into Inotropic Agents Market: Global Trends and Analysis
The inotropic agents market size has grown rapidly in recent years. It will grow from $2.32 billion in 2023 to $2.59 billion in 2024 at a compound annual growth rate (CAGR) of 11.2%. The growth in the historic period can be attributed to education and awareness initiatives, expansion of cardiac treatment options, development of safer agents, improved patient outcomes, regulatory approvals.
The inotropic agents market size is expected to…
